All Stories

  1. Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device

    Article • Patient Preference and Adherence, November 2011, Taylor & Francis

    Madam Nathalie Lambert, Professor Eric J Lawitz